Robot-aided therapy for upper limbs in patients with stroke-related lesions. Brief report of a clinical experience by Bovolenta, Federica et al.
SHORT REPORT Open Access
Robot-aided therapy for upper limbs in patients
with stroke-related lesions. Brief report of a
clinical experience
Federica Bovolenta
1*†, Patrizio Sale
2†, Valentina Dall’Armi
3, Pierina Clerici
1 and Marco Franceschini
2
Abstract
This study was aimed at verifying the improvement on the motor impairment and functionality in 19 patients with
chronic hemiparesis after stroke treated with a robot-aided rehabilitation protocol using the ReoGo™ system (Motorika
Medical Ltd, Israel), and at evaluating the persistence of the effects after 1 month. The study also focused on the actual
possibility of administering the robot-aided therapy with the ReoGo™ for the upper limbs and on the patients’ degree
of acceptance and compliance with the treatment. Subjects underwent an assessment prior to the start of the
rehabilitation project (T-1), one at the start (T0), one at the end of the treatment (T1) and one after one month from the
end of the treatment (T2). The following tests were administered: (i) Fugl-Meyer (FM) upper limb; Ashworth scale (AS);
Functional Independence Measure (FIM™) (T-1 - T2); (ii) strength evaluation; Visual Analogue Scale (VAS) for pain;
Frenchay Arm test (FAT); Box and Block test (BBT); Timed Up and Go (TUG) test (T0 - T2). Additionally, the Euro-QoL
questionnaire and a VAS for the treatment satisfaction were administered to the subjects. Non-statistical difference of
scores at T-1 and T0 on almost the entire battery of tasks suggested a stable patients’ performance prior to the start of
the rehabilitation. With the exception of the Medical Research Council (MRC) and the AS sub-scales measuring -as
appropriate- strength and spasticity of the shoulder, triceps and wrist, all scores showed a significant increase between
T0 and T1. The improvement on the pain could not be proved significant (p = 0.10). A significant increase between T0
and T2 was found for all assessment scores, with the exception of the MRC for external shoulder rotators (p = 0.05) and
of the AS for shoulder (p = 0.32) and wrist (p = 0.08). Substantial stability was observed between T1 and T2. Patients
were capable of completing the treatment and showed good participant satisfaction. This pilot study led to the finding
of a clinical improvement and excellent patients compliance. It is possible that the learning process experienced by the
patients was robot-dependent, especially in consideration of the general maintenance of the achievements observed
on all activities.
Stroke is currently the most important cause of disability
in industrialized countries; it is the main cause of func-
tional impairment of the upper limbs, with important
effects on participation to activities of daily living [1]. The
upper limbs remain non-functional at 6 months post
stroke in 30%-66% of cases, while only 5%-20% of the
patients fully recover upper limbs functionality [2]. In the
last 10 years rehabilitative therapeutic interventions have
been developed to provide the best possible treatment
both in acute and chronic phases. In this context, research
showed that an efficient treatment must be intensive and
specific [3], repetitive, functional and motivating for the
individual [4,5] in order to allow for a continuous progres-
sion in the process of learning, acquisition and generaliza-
tion [6,7]. The development of robot-aided tools for
neurological rehabilitation is a very stimulating prospective
when considering their highly rehabilitative potentials
[8-10]. The objective of this study is to verify the improve-
ment on the motor impairment and functionality after a
robot-aided rehabilitation treatment with the ReoGo™
system and the persistence of the effects after 1 month.
A focus will also be towards the actual possibility of
administering the robot-aided therapy for the upper limbs
with the ReoGo™ system and on the patients’ degree of
acceptance and compliance with the treatment. Subjects
with stroke (chronic hemiparesis) and with the following
* Correspondence: federica.bovolenta@libero.it
† Contributed equally
1Medicine Rehabilitation NOCSAE Hospital AUSL of Modena, Modena, Italy
Full list of author information is available at the end of the article
Bovolenta et al. Journal of NeuroEngineering and Rehabilitation 2011, 8:18
http://www.jneuroengrehab.com/content/8/1/18 JNER
JOURNAL OF NEUROENGINEERING 
AND REHABILITATION
© 2011 Bovolenta et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.inclusion criteria were prospectively recruited into this
“before-after” study: (a) first acute event of cerebrovascular
stroke; (b) unsuccessful conclusion of a previous rehabili-
tation program (with no evident improvement of motility
recovery); (c) discontinuation from any upper limb rehabi-
litation treatment for at least 1 month prior to the first
visit. The following subjects were not included in the
study: (a) patients with severe cognitive, linguistic or per-
ceptive impairment (Mini Mental State Examination
(MMSE) < 24); (b) patients who refused consent to the
study; (c) patients who interrupted the robotic treatment
for more than 3 days. If the treatment was interrupted for
less than 3 days, all missed sessions were recovered. All
recruited patients signed an informed consent. Each
patient underwent a treatment cycle using the ReoGo™
system. The treatment consisted of a total of 20 sessions
lasting 45 minutes each, 5 days a week, for a total period
of 4 weeks; the rehabilitative protocol designed by us con-
sisted of exercises aimed at improving both movement
type (i.e., the joints involved, with a proximal-distal pro-
gression) and mode of execution of the movement itself,
with progression from passive movement to free move-
ment. Forearm support was used during treatment. Speci-
fic tasks are described in Table S1, Additional file 1.
The first visit took place 1 month prior to the start of
the treatment (T-1). Following visit were scheduled:
immediately before the start of the treatment (T0),
immediately after the end of the treatment period (T1),
and after 1 month (T2) during which period patients
underwent no specific rehabilitation for the upper limb.
The assessment tasks were: Fugl-Meyer (FM) for upper
limb with its subtest: Motor function, Sensation, Passive
Joint Motion, Joint Pain. [Lindmark, Hamrin 1988)
[11,12]; Strength evaluation of 10 muscles, according
to the Medical Research Council (MRC) criteria [13];
Ashworth (AS) elbow, wrist and shoulder sub-scales for
spasticity [14]; Visual Analogue Scale (VAS) for upper
limb pain; Frenchay Arm test (FAT) [15]; Box and Block
test (BBT) [16]; Functional Independence Measure
(FIM™) motor sub-score [17,18]. In addition, subjects
underwent a comprehensive evaluation using the Timed
Up and Go (TUG) test [19]. Lastly, the Euro-QoL ques-
t i o n n a i r ef o rt h eq u a l i t yo fl i f e[ 2 0 , 2 1 ]a n daV A Sf o r
treatment satisfaction were also administered to the sub-
jects. The evaluations timeline is detailed in table 1.
Specific aims of this study were: (i) to verify that sub-
jects’ performance was stable prior to the start of the
robotic treatment. This was done by comparing the per-
formance at T-1 and T0 with regards to the FM, FIM™
and AS; (ii) to detect the improvement on subject’sc l i n i -
cal status and its maintenance at 1 month after the com-
pletion of the rehabilitation program. This was done by
comparing the change in performance on all tests from
T0 to T1 and T2 and from T1 to T2. The Wilcoxon test
for paired data was applied to perform all time compari-
sons. The critical limit for significance was set at p <
0.05. The statistical software STATA/SE Release 10 was
used to carry out all statistical evaluations.
Nineteen subjects were included in the study, 13
(68.42%) were males and 6 (31.58%) females; 7 indivi-
duals (36.84%) presented with left hemiparesis and 12
(63.16%) with right hemiparesis. The sample average age
was 55.74 ± 12.60 years, with a range of 26-71; the aver-
age time elapsed since the acute event was 57.37 ±
92.37 months, with a range of 8-295 months. Table 2
summarizes descriptive, clinical and psychological sam-
ple information. The follow-up visit (T2) could not be
carried out on 3 patients because of difficulties encoun-
tered by their relatives in reaching the hospital.
Stability in the patients’ performance prior to the start
of the rehabilitative treatment, supported by the non-
statistical difference of scores at T-1 and T0 for all
tasks, with the exclusion of the motor FIM™ (p = 0.01),
was observed.
The improvement observed in the patients’ perfor-
mance from T0 to T1 reached statistical significance for
the FM upper limb (p < 0.01) sub-scores, for the AS
elbow sub-scale (p < 0.01), for the motor FIM™ (p <
0.01), for all muscles’ strength according to the MRC cri-
teria -with the exception of the external rotators of the
shoulder (p = 0.18), triceps (p = 0.06), wrist flexors (p =
0.13) and extensors (p = 0.08)-, for the BBT (p < 0.01),
for the TUG test (p = 0.01), and for the FAT (p < 0.01).
Similarly, statistical evidence for an improvement from
T0 to T2 was found for the FM upper limb (p < 0.01),
for the AS elbow sub-scale (p = 0.01), for the motor
FIM™ (p < 0.01), for the VAS pain (p < 0.01), for all
muscles’ strength -with the exception of the external
rotators of the shoulder (p = 0.05)-, for the BBT (p =
0.01), for the FAT (p < 0.01) and for the TUG test (p =
0.02). Statistical evidence in favor of a progressive
Table 1 Timeline of the evaluations performed on all
patients during the study period
Tests T-1 T0 T1 T2
Fugl-Meyer motor function XX X X
MRC* -X X X
Ashworth Scale XX X X
Visual Analogue Scale pain -X X X
Frenchay Arm Test -X X X
Box & Block Test -X X X
FIM™ motor XX X X
Time Up and Go Test -X X X
EURO-QoL* -X - X
Visual Analogue Scale satisfaction -- X -
*MRC: strength evaluation of 10 muscles, according to the Medical.
Research Council (MRC) criteria; EURO-QoL.
questionnaire on quality of life perception.
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FIM™ (p = 0.01) and the VAS (p = 0.02). The percep-
tion of the quality of life, as measured by the Euro-QoL,
did not show statistically significant variations over time;
the VAS for patients’ treatment satisfaction had an aver-
age score of 98.68 ± 4.02. Table 3 summarizes the sam-
ple performance over time at all clinical tests.
The study showed a positive evolution of the limita-
tion of activity and functionality for all subjects.
T h es a m p l eh a dab a s e l i n eF Mi nl i n ew i t ho t h e rs t u -
dies (Table 3) [10,22,23] and so was the increase in FM
score (Lindmark and Hamrin) [10,22,23].
All subjects showed excellent compliance and remark-
able satisfaction, highlighted by the results of the VAS
rating and the absence of dropouts associated to intoler-
ance to treatment. The increase in the motor FIM™
and the decrease on the VAS for the pain might be due
to different strategies developed by the patients for com-
pensating their motor deficits. This data is in accor-
dance with Lauretani [2010] who observed a functional
recovery after a rehabilitation treatment in patients dis-
charged to home [24]. The statistically significant
increase between T0 and T2 shows how the improve-
ment observed immediately after completion of the
rehabilitative protocol was maintained over time, even
though the sample under examination included subjects
in a stable disease stage. Our results are in accordance
with those of Bosecker 2010, who studied 111 indivi-
duals with chronic impairment caused by stroke and
trained with a robot [25]. Such a robot-guided treatment
must be task-oriented, functional and motivating for the
patient [4,5,23], and therefore capable of determining a
process of learning, acquisition and generalization [6,7].
The use-dependent robot-aided instruments (intensive
and repetitive treatment) may favor functional reorgani-
zation phenomena, typical of neuronal plasticity [3,26].
Our experience is also in line with studies [6,27] that
confirm how this type of treatment does not negatively
affect spasticity: in our sample, the elbow AS score was
reduced, while no change, nor an increase in spasticity,
was detected for the other joints [28]. The positive effect
observed on the quality and speed of the walking perfor-
mance, assessed through TUG both at T1 and T2, is
also interesting. This data conforms with Esquinazi
paper [29]. The results obtained from our study suggest
that a motor and functional recovery takes place and
can be interpreted as a possible result of the process of
adaptation. In addition, it was also possible to observe a
motor learning and generalization process, confirmed by
the baseline improvements observed at T1 and main-
tained until 1 month after (T2), an indication of the fact
that patients were not in a spontaneous recovery stage.
Further research with higher statistical power is neces-
sary. The enrolment of a control group would provide a
term of comparison for the identification of the time-
dependent effects, thus addressing the question of
whether improvements are therapy-dependent or effec-
tively acquired. Eventual relationships between clinical
outcome and potentially influential factors should be
explored. Stronger evidence would be beneficial when
coming to make the decision of using robotic devices as
an integral part of the rehabilitation team activities,
within a rehabilitation project designed accordingly to
the specifications and objective requirements of each
patient. In this context, subjects at different disease
stages (i.e. patients in the acute and sub-acute phases)
should be considered in future research. Indeed, while
there are several studies with various robotic systems for
the upper limb in acute/sub-acute stroke patients
[30-32], only one study with ReoGo™ system in the
sub-acute phase [33] has been carried out so far. The
implementation of different protocols according to the
severity of the impairment should also be considered.
The results obtained in terms of recovery in functional-
ity and the restriction of participation, as well as in
patients’ compliance and operator satisfaction, are
encouraging in spite of the limitations of this study. The
significant improvements found from the baseline mea-
surements to the end of the treatment may be an
Table 2 Demographic, clinical and psychological sample
N % Mean ± Std.Dev
Time since Stroke 19 57.37 ± 92.37
Age 19 55.74 ± 12.60
Gender Males 13 68.42
Females 6 31.58
Affected Side Left 7 36.84
Right 12 63.16
Disease Severity Mild 9 47.37
Moderate 9 47.37
Severe 1 5.26
EURO-QOL
MOB Yes 3 15.79
No 15 78.95
Unknown 1 5.26
CP Yes 10 52.63
No 7 36.84
Unknown 2 10.53
AU Yes 3 15.79
No 15 78.95
Unknown 1 5.26
DD Yes 4 21.05
No 14 73.69
Unknown 1 5.26
AD Yes 8 42.11
No 10 52.63
Unknown 1 5.26
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Page 3 of 6Table 3 Performance at the clinical assessment tasks
T-1 (N = 19) T0(N = 19) T1 (N = 19) T2(N = 16)
Mean ± Std.
Dev.
Median Min;
Max
Mean ± Std.
Dev.
Median Min;
Max
Mean ± Std.
Dev.
Median Min;
Max
Mean ± Std.
Dev.
Median Min;
Max
Fugl-Meyer Test (n = 18) Upper Limb 31.33 ± 17.42 33.5 5; 54 31.21 ± 16.92 33 7; 55 40.37 ± 18.57 49
b 9; 62 41.75 ± 18.95 49.5
b 9; 63
Ashworth Scale (n = 18) Shoulder 0.67 ± 0.77 0.5 0;2 0.37 ± 0.6 0 0;2 0.16 ± 0.37 0 0; 1 0.25 ± 0.77 0 0;3
Elbow 1.67 ± 0.91 1.5 0;3 1.79 ± 0.98 2 0;3 1.26 ± 0.93 1
b 0;3 1.44 ± 1.03 1
b 0;3
Wrist 0.89 ± 1.02 1 0;4 1 ± 1 1 0;4 0.68 ± 0.67 1 0;2 0.63 ± 0.62 1 0;2
FIM™ (n = 16) Motor 80.63 ± 16.22 82 53; 126 82.26 ± 13.88 83
a 56; 126 85.21 ± 11.84 86
b 69; 126 85.94 ± 6.32 88.5
b,
c 69; 91
Visual Analogue Scale Pain 22.05 ± 26.33 15 0;80 11.58 ± 20.21 0 0;75 0 ± 0 0b,c 0;0
Medical Research Council, muscles’
strength criteria
Trapezius 3.37 ± 0.76 3 2;5 3.79 ± 0.79 4
b 3;5 3.94 ± 0.77 4
b 3;5
Deltoid 3.68 ± 0.58 4 2;4 4.37 ± 0.6 4
b 3;5 4.56 ± 0.63 5
b 3;5
Pectoralis
Major
3.74 ± 1.19 4 0;5 4.47 ± 0.77 5
b 2;5 4.75 ± 0.45 5
b 4;5
External
Rotatores
3.58 ± 1.12 4 0;5 4.11 ± 1.15 4
b 0;5 4.25 ± 1.29 5
b 0;5
Internal
Rotatores
32 ± 1.57 4 0;4 3.32 ± 1.57 4 0;5 3.56 ± 1.46 4 0;5
Biceps Brachii 3.95 ± 0.97 4 2;5 4.53 ± 0.61 5
b 3;5 4.81 ± 0.4 5
b 4;5
Triceps Brachii 3.74 ± 1.28 4 0;5 4.05 ± 1.08 4 1;5 4.31 ± 1.14 5
b 1;5
Flexor Carpi 3 4 0; 53 4 0;5 3.32 ± 1.67 4 0;5 3.63 ± 1.63 4
b 0;5
Extensor Carpi 2.84 ± 1.38 3 0;4 3.21 ± 1.51 4 0;5 3.5 ± 1.41 4
b 0;5
Latissimus
Dorsi
2.74 ± 1.24 3 0;4 3.47 ± 1.12 4
b 1;5 3.94 ± 1.06 4
b 1;5
Box & Block Test 11.89 ± 11.69 12 0;38 16.95 ± 15.6 17
b 0;45 17 ± 15.9 17
b 0;54
FrenchayArm Test 2.47 ± 1.81 3 0;5 3.26 ± 2.05 5
b 0;5 3.31 ± 1.96 4.5
b 0;5
Time Up and Go Test 18.58 ± 7.9 17 10; 40 17.47 ± 8.55 14
b 9; 38 16.25 ± 7.01 15
b 8;34
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6indication of a clinical-functional improvement, thus a
presumed effectiveness of the REOGo™ instrument
[26,34-36]. In conclusion, further research with neuro-
imaging and/or TMS patterns, with an adequate control
group, will be imperative to confirm these results.
Additional material
Additional file 1: Reo Go Protocol. The specific rehabilitation tasks. The
assessment process is designed to view the patient’s ability to perform
specific exercises over time. The system is capable of measuring and
displaying the patient’s progress. The screen displays the activities of the
patient on the machine, according to exercise dates. The following
parameters can be changed: ￿ Number of repetitions - how many
times the exercise will be repeated ￿ Speed - Values range between 10%
and 200%. The 100% value is 5 degrees per second. ￿ Force (the
resistance force of the joystick) - 3 possible values - High, Medium, and
Low. Low force will require less force from user to initiate movement. ￿
Motion mode - Guided, Initiated, Step Initiated, Follow assist or Free ￿
Scaling - Each exercise can be scaled according to patients’ comfortable
range of motion -i.e. stretched or squeezed from a center point. Values
range from 0% to 200% of the original exercise. ￿ Random - Each
exercise can be run in Random mode, i.e. the computer selects the next
point randomly from the points of the exercise. ￿ 2D/3D mode - for
every exercise, the radius of motion may be fixed (2D motion) or
changeable (3D motion). The system provides the following exercise
operating methods: ￿ Guided mode - the patient is actively assisted by
the system. ￿ Initiated mode - the patient initiates each trajectory
segment (between two successive recorded points) by himself,
overcoming a predefined force threshold and then is actively assisted by
the system for the rest of the segment ￿ Step Initiated mode - similar
to Initiated, but each trajectory segment (between two successive
recorded points), is further divided to predefined “sub-segments”
(3 degrees each) to overcome force threshold. ￿ Follow Assist mode -
the handle moves at a slow speed towards the target. Once the user
applies force to the handle in the specified direction the speed will be
increased. ￿ Free mode - the patient actively leads the movement by
himself. A summary of total training time is also displayed. Pressing the
individual dates will display a summary of training for the specific date.
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